130 related articles for article (PubMed ID: 17577797)
1. Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: a case report.
Cil T; Kaplan MA; Altintas A; Pasa S; Isikdogan A
Leuk Lymphoma; 2007 Jun; 48(6):1247-9. PubMed ID: 17577797
[No Abstract] [Full Text] [Related]
2. High-dose cytosine arabinoside-induced symptomatic bradycardia.
Wayangankar SA; Patel BC; Parekh HD; Holter JL; Lazzara R
J Cardiovasc Med (Hagerstown); 2015 Jan; 16 Suppl 1():S38-41. PubMed ID: 21178637
[TBL] [Abstract][Full Text] [Related]
3. Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.
Peters WG; Willemze R; Colly LP; Guiot HF
Neth J Med; 1987 Feb; 30(1-2):64-74. PubMed ID: 3473310
[No Abstract] [Full Text] [Related]
4. Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.
Babaoglu MO; Karadag O; Saikawa Y; Altundag K; Elkiran T; Yasar U; Bozkurt A
Eur J Clin Pharmacol; 2004 Aug; 60(6):455-6. PubMed ID: 15232664
[No Abstract] [Full Text] [Related]
5. [High dose cytosin arabinoside induced sinus bradycardia in a Hodgkin's lymphoma patient].
Teke HÜ; Karagülle M; Akay OM
Anadolu Kardiyol Derg; 2013 Sep; 13(6):618-9. PubMed ID: 24064095
[No Abstract] [Full Text] [Related]
6. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia.
Altundag O; Altundag K; Celik I; Turker A; Kars A
Am J Hematol; 2004 Apr; 75(4):263-4. PubMed ID: 15054828
[No Abstract] [Full Text] [Related]
7. [Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
Taverna C; Jacky E; Sauter C
Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1117. PubMed ID: 9691347
[No Abstract] [Full Text] [Related]
8. [Cytosine-arabinoside in the treatment of acute leukemias].
Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
[No Abstract] [Full Text] [Related]
9. Fludarabine-induced bradycardia in a patient with refractory leukemia.
Chung-Lo W; Hsieh CY; Chiu CF; Bai LY
Ann Saudi Med; 2010; 30(3):246-7. PubMed ID: 20427948
[No Abstract] [Full Text] [Related]
10. Resident rounds. Part III: Neutrophilic eccrine hidradenitis in the setting of acute myelogenous leukemia treated with cytarabine.
Shlapak D; Kerisit K; Lin C; Wang A; Stumpf B
J Drugs Dermatol; 2013 Feb; 12(2):231-2. PubMed ID: 23550319
[No Abstract] [Full Text] [Related]
11. Neutrophilic eccrine hidradenitis induced by cytarabine.
Grahovac M; Maximiliane Ehmann L; Flaig M; Reibke R; Wollenberg A
Acta Dermatovenerol Croat; 2012; 20(4):272-5. PubMed ID: 23317491
[No Abstract] [Full Text] [Related]
12. A new pattern of cytosine-arabinoside-induced lung toxicity.
Chagnon K; Boissel N; Raffoux E; Dombret H; Tazi A; Bergeron A
Br J Haematol; 2009 Dec; 147(5):771-4. PubMed ID: 19735260
[No Abstract] [Full Text] [Related]
13. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
Miyawaki S; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Omoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Ueda T; Tomonaga M; Ohno R
Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
[No Abstract] [Full Text] [Related]
14. Cytarabine-induced neurotoxicity responding to methyl prednisolone.
Malhotra P; Mahi S; Lal V; Kumari S; Jain S; Varma S
Am J Hematol; 2004 Dec; 77(4):416. PubMed ID: 15551283
[No Abstract] [Full Text] [Related]
15. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
Pellier I; Leboucher B; Rachieru P; Ifrah N; Rialland X
J Pediatr Hematol Oncol; 2006 Dec; 28(12):837-9. PubMed ID: 17164656
[TBL] [Abstract][Full Text] [Related]
16. Evidence for sinoatrial blockade associated with high dose cytarabine therapy.
Stamatopoulos K; Kanellopoulou G; Vaiopoulos G; Stamatellos G; Yataganas X
Leuk Res; 1998 Aug; 22(8):759-61. PubMed ID: 9680105
[TBL] [Abstract][Full Text] [Related]
17. Florid skin rash in acute myeloid leukaemia.
Ammannagari N; Kaewpoowat Q; Ratanapo S; Patel A
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23542647
[No Abstract] [Full Text] [Related]
18. Sweet's syndrome and Pneumocystis carinii pneumonia: two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia.
Chowdhary V; Nityanand S; Prasad KN; Pandey R; Dabadghao S
Eur J Haematol; 2000 Jul; 65(1):72-3. PubMed ID: 10914942
[TBL] [Abstract][Full Text] [Related]
19. Cytosine arabinoside-induced vasculitis.
Ahmed I; Chen KR; Nakayama H; Gibson LE
Mayo Clin Proc; 1998 Mar; 73(3):239-42. PubMed ID: 9511781
[TBL] [Abstract][Full Text] [Related]
20. "Flushing out" cytosine arabinoside from CSF to reverse neurotoxicity.
Bleyer A
J Pediatr Hematol Oncol; 2007 Apr; 29(4):274. PubMed ID: 17414574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
